Schulz-Gasch Tanja, Stahl Martin
Molecular Structure and Design, Pharmaceuticals Division, F. Hoffmann-La Roche AG, Discovery Technologies, Bldg. 092/2.10D, CH-4070 Basel, Switzerland.
Molecular Structure and Design, Pharmaceuticals Division, F. Hoffmann-La Roche AG, Discovery Technologies, Bldg. 092/2.10D, CH-4070 Basel, Switzerland.
Drug Discov Today Technol. 2004 Dec;1(3):231-9. doi: 10.1016/j.ddtec.2004.08.004.
Scoring functions play an essential role in structure-based virtual screening. They are required to guide the docking of candidate compounds to structures of receptor binding sites, to select probable binding modes, and to discriminate binders from non-binders. Although many scoring functions have successfully been used to identify novel ligands for a wide variety of targets, much work remains to be done to avoid incorrect prediction of binding modes and high numbers of false positives. This review gives an overview of the current state of the field and outlines key issues for the further development of scoring functions.:
评分函数在基于结构的虚拟筛选中起着至关重要的作用。它们被要求引导候选化合物与受体结合位点的结构进行对接,选择可能的结合模式,并区分结合剂和非结合剂。尽管许多评分函数已成功用于识别针对各种靶点的新型配体,但仍有许多工作要做,以避免结合模式的错误预测和大量假阳性。本文综述了该领域的当前状态,并概述了评分函数进一步发展的关键问题。